Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| MapLight Therapeutics, Inc. | 175,964 | reported | 11 May 2026 | tx 13+176,269−53,841 |
| PhaseBio Pharmaceuticals Inc | 8,463 | reported | 20 May 2022 | tx 9+271,713 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 11 May 2026 | SALE | MapLight Therapeutics, Inc. | 284 | 27.61 USD | 10b5-1 |
| 11 May 2026 | SALE | MapLight Therapeutics, Inc. | 846 | 28.70 USD | 10b5-1 |
| 11 May 2026 | SALE | MapLight Therapeutics, Inc. | 6,979 | 30.04 USD | 10b5-1 |
| 11 May 2026 | SALE | MapLight Therapeutics, Inc. | 5,808 | 30.56 USD | 10b5-1 |
| 04 May 2026 | SALE | MapLight Therapeutics, Inc. | 9,030 | 27.50 USD | 10b5-1 |
| 04 May 2026 | SALE | MapLight Therapeutics, Inc. | 3,908 | 28.29 USD | 10b5-1 |
| 04 May 2026 | SALE | MapLight Therapeutics, Inc. | 296 | 29.56 USD | 10b5-1 |
| 04 May 2026 | SALE | MapLight Therapeutics, Inc. | 683 | 30.08 USD | 10b5-1 |
| 05 Feb 2026 | GRANT_AWARD | MapLight Therapeutics, Inc. | 7,730 | 0.00 USD | |
| 05 Feb 2026 | GRANT_AWARD | MapLight Therapeutics, Inc. | 31,395 | 0.00 USD | deriv |
| 27 Jan 2026 | TAX_WITHHOLDING | MapLight Therapeutics, Inc. | 26,007 | 17.98 USD | |
| 27 Oct 2025 | GRANT_AWARD | MapLight Therapeutics, Inc. | 27,098 | 0.00 USD | |
| 27 Oct 2025 | GRANT_AWARD | MapLight Therapeutics, Inc. | 110,046 | 0.00 USD | deriv |
| 20 May 2022 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 4,831 | 0.68 USD | |
| 24 Feb 2022 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 87,500 | 0.00 USD | deriv |
| 24 Feb 2022 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 18,750 | 0.00 USD | deriv |
| 19 Nov 2021 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 1,545 | 2.01 USD | |
| 20 May 2021 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 1,088 | 2.80 USD | |
| 05 Feb 2021 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 36,000 | 0.00 USD | deriv |
| 20 Nov 2020 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 999 | 3.00 USD | |
| 12 Feb 2020 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 55,000 | 0.00 USD | deriv |
| 07 Oct 2019 | GRANT_AWARD | PhaseBio Pharmaceuticals Inc | 66,000 | 0.00 USD | deriv |